Handelsbanken Fonder’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Handelsbanken Fonder’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,504	Closed	-$289K	–	1766
2021 Q3	$289K	Hold	8,504	–	–	﹤0.01%	1599
2021 Q2	$311K	Sell	8,504 -1,100	-11%	-$42.6K	﹤0.01%	1622
2021 Q1	$431K	Hold	9,604	–	–	﹤0.01%	1272
2020 Q4	$548K	Hold	9,604	–	–	﹤0.01%	1110
2020 Q3	$493K	Hold	9,604	–	–	﹤0.01%	997
2020 Q2	$574K	Buy	+9,604	New	+$514K	﹤0.01%	904

Other funds holding DCPH

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Handelsbanken Fonder's DCPH Position: Q4 2021 in Review

Handelsbanken Fonder sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 8,504 shares — an estimated $289K sold.

Handelsbanken Fonder first reported a position in DCPH in Q2 2020 and held it in 6 quarters. The position peaked at $574K in Q2 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Handelsbanken Fonder reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Handelsbanken Fonder sold 8,504 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $289K.
Handelsbanken Fonder first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
Handelsbanken Fonder's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $574K in Q2 2020.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.